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Abstract
Background: Comorbidity is known to affect length of hospital stay and mortality after trauma but less is known
about its impact on recovery beyond the immediate post-accident care period. The aim of this study was to
investigate the role of pre-existing health conditions in the cost of recovery from road traffic injury using health
service use records for 1 year before and after the injury.
Methods: Individuals who claimed Transport Accident Commission (TAC) compensation for a non-catastrophic
injury that occurred between 2010 and 2012 in Victoria, Australia and who provided consent for Pharmaceutical
Benefits Scheme (PBS) and Medicare Benefits Schedule (MBS) linkage were included (n = 738) in the analysis. PBS
and MBS records dating from 12 months prior to injury were provided by the Department of Human Services
(Canberra, Australia). Pre-injury use of health service items and pharmaceuticals were considered to indicate
pre-existing health condition. Bayesian Model Averaging techniques were used to identify the items that were most
strongly correlated with recovery cost. Multivariate regression models were used to determine the impact of these
items on the cost of injury recovery in terms of compensated ambulance, hospital, medical, and overall claim cost.
Results: Out of the 738 study participants, 688 used at least one medical item (total of 15,625 items) and 427 used
at least one pharmaceutical item (total of 9846). The total health service cost of recovery was $10,115,714. The
results show that while pre-existing conditions did not have any significant impact on the total cost of recovery,
categorical costs were affected: e.g. on average, for every anaesthetic in the year before the accident, hospital cost
of recovery increased by 24 % [95 % CI: 13, 36 %] and for each pathological test related to established diabetes,
hospital cost increased by $10,407 [5466.78, 15346.28]. For medical costs, each anaesthetic led to $258 higher cost
[174.16, 341.16] and every prescription of drugs used in diabetes increased the cost by 8 % [5, 11 %].
Conclusions: Services related to pre-existing conditions, mainly chronic and surgery-related, are likely to increase
certain components of cost of recovery after road traffic trauma but pre-existing physical health has little impact on
the overall recovery costs.
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Background
Road traffic crashes are one of the most common exter-
nal causes of injury leading to hospitalisation among
young people in high income countries throughout the
world, including Australia [3], New Zealand [23], Europe
[10] and the United States [22, 38]. In the United States,
the economic cost of motor vehicle accidents was esti-
mated to be close $277 billion in 2010 equivalent to
1.9 % of the Gross Domestic Product (GDP) [4]. The so-
cial costs of road traffic crash injury in Australia in 2006
were estimated to be $18,000 million, which is equal
to about 1.7 % of the GDP. In that year, 1602 people
died and more than 31,000 injured in road traffic
crashes. Sixty seven percent of these injured people
stayed one or more nights at the hospital and 4619
people suffered disability, from which 1270 people had
“severe or profound limitation”. Cost of these injuries
were approximately $2.4 million per fatality, approxi-
mately $214,000 per hospitalised injury (including
disability-related costs), and approximately $2200 per
non-hospitalised injury” [3].
Several studies have found that health conditions
(or comorbidity) that existed before the crash event
(e.g. diabetes, heart disease) can be predictive of mortality
after serious injury. This has been demonstrated in trauma
patients in the acute care setting [20, 21, 30, 32, 35] and
among older adults aged ≥65 years admitted to emer-
gency departments for home or road injury [7]. Pre-
existing health conditions have also been shown to predict
morbidity after trauma. In particular, such correlations
have been found for a number of chronic comorbid condi-
tions with respect to its impact on post injury length of
hospital stay. Disability at 12 months post-injury has also
been found to be affected by pre-injury comorbidity
among orthopaedic injury patients [12].
While prior literature suggests that pre-existing health
conditions have a deleterious effect on post injury out-
comes, the nature and extent of this relationship is not
well documented. Research on the impact of comorbid-
ity on trauma outcomes has mainly been conducted
from a clinical perspective, with a focus on improving
triaging and trauma management procedures. Minor in-
jury that does not require hospitalisation is not captured
in trauma-centre based research and little is known
about the relationship between pre-existing health con-
ditions and outcomes of minor injury. One of the main
advantages in our study is that we use comprehensive
linkage dataset on medical and pharmaceutical usage.
Thus, the analysis is not limited to hospitalised patients
and their services used in hospital.
While often overlooked because of their minor injury
status, people with non-hospitalised injuries frequently
have delayed recovery. Recent studies have shown that
non-hospitalised injuries account for the majority of the
injury incidence and the majority of the injury burden
[16]. Of the compensable road traffic injuries in Victoria,
Australia, approximately 70 % of injury claims are for in-
juries that do not require hospitalisation, and little is
known about the impact of comorbidity on cost health
service use after injury in this group. Given the minor
nature of many of the non-hospitalised injuries, much of
the long term burden in this group may be due to the
adverse impact of pre-existing conditions rather than be-
ing mainly the consequence of the injury itself. Increased
levels of post injury care and additional tests and proce-
dures may be indicated in people with comorbidity and
this may independently increase the post injury economic
costs related to care for this group.
If there is a relationship between pre-existing health
conditions and cost of road traffic crash injuries, then
we could expect over the next 20 years to see a dramatic
escalation of these costs and substantial challenges in
providing health services. The population is ageing as
the baby boom generation (birth years 1946–1965) is
reaching retirement age. The baby boom generation is
more likely to drive a car than the generations before
them, and baby boomers are likely to continue driving
as they age. The road user population can therefore be
expected to age more rapidly than the general popula-
tion [28]. Chronic conditions are likely to be prevalent
in an ageing population and have previously been as-
sociated with trauma outcomes; these include diabetes
mellitus [13, 21] and cardiovascular disease [20, 21].
As the road user population ages, the prevalence of
chronic disease among road users, and among trauma
victims, can be expected to increase. Insight into the
effect of pre-existing chronic disease on injury recov-
ery, and the cost of recovery, is essential if the larger
health care system (of which the road transport injury
compensation schemes are a part) is to anticipate and
accommodate a potentially increasing economic and
social burden.
With the purpose of helping prepare health and disability
care industries meet their impending challenges, we under-
took a study that aimed to quantify the effect of pre-
existing health conditions on the cost of recovery from
road traffic injury. Consistent with the study purpose, we
undertook economic analyses from a payer perspective and
used administrative health care system and traffic crash
compensation scheme data as inputs to our models. The
chosen study region, the state of Victoria in Australia, has
a universal population coverage of health service delivery,
as well as pharmaceutical and road traffic injury insurance
coverage. Using a comprehensive dataset obtained by link-
ing the three relevant administrative databases of medical
insurance, pharmaceutical benefits, and traffic injury cover-
age, this study offers a unique opportunity to evaluate the
role of comorbidity in injury recovery.
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Methods
Setting
Victoria is a state in south east of Australia with a popula-
tion of 5,821,300 (March 2014). The Transport Accident
Commission (TAC) is a state-government organisation re-
sponsible for paying the cost of treatment rehabilitation
services, disability services, income assistance, travel and
household support services to people injured in traffic ac-
cident in the state of Victoria regardless of whether the
client was at fault. It is a population based scheme funded
from annual car registration payments by Victorian mo-
torists. The treatment payments include the categories
such as ambulance, hospital and medical services, phar-
macy items, and equipment. There is AUD$623 (as of
2014) medical excess for these categories excluding the
ambulance and hospital services. TAC also pays for other
services such as child care, loss of earning, as well as lump
sum compensation such as impairment benefit.
Medicare Benefits Schedule (MBS) is an Australian
Federal Government scheme that “provides access to
medical and hospital services for all Australian residents
and certain categories of visitors to Australia. Medicare
benefits are claimable only for ‘clinically relevant’ services
rendered by an appropriate health practitioner” [17].
Pharmaceutical Benefits Scheme (PBS), (also and Australian
Federal Government initiative) “gives all Australian
residents and eligible overseas visitors access to prescrip-
tion medicine in a way that is affordable, reliable and
timely”. MBS and PBS are administered by the Department
of Human Services, Canberra, Australia.
Study design
A consented data linkage study was undertaken, with
the inception cohort being a subset of persons with
compensable road traffic injury. Research data was ob-
tained by linking of the TAC claims data of consenting
study participants, with health data from the MBS and
PBS provided by the Department of Human Services
(Canberra, Australia) to obtain relevant information
about the cohort for 12 months prior to and 12 months
following the date of their injury. The study aim was ad-
dressed by quantifying the association between the pre
injury health (determined from health service and
pharmaceutical use) and post injury claim cost, control-
ling for confounders.
Study population
People registered in the Transport Accident Commission
claims database with an incident injury from a road
crash in Victoria dating between 17/07/2011 and 22/07/
2012 were invited to participate. Potential study partici-
pants were excluded if they had (1) an acquired brain in-
jury; (2) Glasgow Coma Scale is less than 9;(3) length of
Post Traumatic Amnesia greater than 6 days; or (4) one
or more of the following injuries: paraplegia, quadriple-
gia, amputation above elbow or above knee, severe burns
(full thickness, approximately >30 % whole body) and
blindness due to nerve severance. Also, claimants who
were involved in an accident where there was a fatality
were excluded.
Ethics, process and study approval
The study was first approved by the Monash University
Human Research Ethics Committee (MUHREC): Project
number CF12/0875 – 2012000398 ‘After MUHREC
approval, the study was also evaluated by the External
Request Evaluation Committee at the Department of
Human Services in Canberra.
Study invitations were mailed to participants in three
batches: a pilot mail-out to test the study logistics,
followed by two main mail-outs. For the final (and largest)
mail-out, the initial study invitation was followed by a re-
minder package including a reminder letter, a new set of
forms (explanatory statement and consent form) and a
reply paid envelope addressed to Monash University.
Contact details of eligible participants were provided
to the printer by the TAC. Reply paid envelopes were
provided by the researchers at the Monash Injury Re-
search Institute (MIRI). Study invitations were printed
and posted by the printer: name, address, date of birth
and study linkage dates (based on the claim date) were
pre-filled on the Medicare consent form. The re-
searchers at MIRI were not provided with contact details
of the selected sample; they only received the signed and
posted consent forms of participants providing their
consent. The TAC was not informed about participation
of individual clients. The Department of Human Ser-
vices provided the Medicare and Pharmaceutical Benefits
Scheme records starting 12 months prior to, through to
18 months after the claim onset, of participants who
provided consent. This dataset was linked to TAC claims
and payments records from the Compensation Research
Database at the Institute for Safety, Compensation and
Recovery Research (ISCRR). For this analysis, the linked
dataset did not contain personal identifiers and was re-
stricted to pre-injury MBS and PBS records only, linked
with TAC payments that occurred in the 12 months fol-
lowing the injury (i.e. a 12-months follow-up).
Variables and data sources
Participant status, injury, age and sex
Participant information was obtained from the TAC
claims records: this includes gender, age, socio-economic
indicators for clients’ residential areas, role in the acci-
dent (e.g. driver, cyclist, motor-cyclist, pedestrian, and
passenger), number of vehicles involved in the accident,
location of accident (metropolitan, country or interstate),
and type of injury such as musculoskeletal (e.g. contusion),
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orthopaedic (e.g. fractures and dislocations), brain injury
and internal injury.
Pre-existing health conditions
Pre-injury health conditions (comorbidity) were inferred
from information obtained from both the Medicare Bene-
fits Schedule (MBS) and Pharmaceutical Benefits Scheme
(PBS) records for 12 month period immediately prior to
the injury. Although health service use and pharmaceut-
ical records do not provide clinically validated disease
diagnoses, overall service use reflects the intensity of
health care utilisation prior to injury. Indications of the
prevalence of these conditions were based on the use of
pharmaceuticals as well as specific diagnostic and thera-
peutic procedures.
Cost of injury
In this study, the cost of injury refers to the direct cost
of any health service use which is compensated by the
TAC. It includes the cost of ambulance, hospital and
medical services and is measured in Australian dollars.
The cost of injury was determined from injury compen-
sation payment records over 12 months following the in-
jury. The dataset holds a record of every payment made
by the TAC to a client or provider. Progression from
short-term to long-term costs was considered, by mak-
ing the distinction between the 3, 6 and 12 months cost
of recovery. Taking into account the biased distribution
of service cost among participants coming from heavy
service use by a small number of participants, both ori-
ginal and log values of service count are used.
Data management and analysis
Data from the MBS and PBS were used to create
markers of pre-existing health in the following manner.
The 6000 different items of service available in MBS
data were used to derive information about underlying
health of the participants. The Bayesian Model Aver-
aging (BMA) was used to select the most efficient MBS
items in the dataset to represent comorbidities for subse-
quent inclusion in the final analytic multivariate regres-
sion models. The BMA is commonly accepted approach
when there is model uncertainty, and widely used in
several disciplines such as economics, political science,
ecology, environmental science [5, 11, 26, 27, 37]. To
ensure that the multicollinearity across included vari-
ables did not affect measured uncertainty within the
MBA models, dilution method was used as suggested by
Durlauf et al. [9], which essentially puts a greater penalty
to models with highly collinear variables.
To categorise treatment for pre-existing health condi-
tions, PBS codes were provided with corresponding
Anatomical Therapeutic Chemical (ATC) classification
system codes [19]. The ATC coding has five levels but
considering the level of data availability, the top two
levels only were used in the analysis.
Results
Sample characteristics
In total 10,998 potential study participants were invited
to participate. Informed consent for inclusion in the
study with both MBS and PBS data linkage was obtained
from 738 TAC clients (i.e.7 %). Comparing the partici-
pating sample with the invited sample in terms of claim
information, women were more likely to participate than
men (RR = 1.36, 95 % CI: 1.17, 1.59). Study participants
were older with a median age of 50 years (25th and 75th
percentiles of 35, 63); compared to a median age of
39 years (25th and 75th percentiles of 26, 54) years in the
mail-out sample overall. Clients with claims for muscu-
loskeletal injuries were less likely to participate than
those with orthopaedic (RR = 1.59, 95 % CI: 1.27, 1.98)
or other injuries (RR = 1.57, 95 % CI: 1.24, 1.98). All the
claimants were followed for at least 1 year, though 33 %
did not have any compensation received beyond the day
of accident, 7 % received payments only between 1 and
7 days after the accident and 20 % were compensated
only between one and 26 weeks after the accident.
MBS data
Out of the 738 study participants, 688 used at least one
MBS item in the year prior to their accident. The total
number of pre-injury service items was 15,625. Following
MBS categorisation, all medical services were grouped
under eight main categories and 91 groups. Overall, 85 %
of the services were categorized as attendance or path-
ology services. While the greatest share of the overall
cost belongs to attendances, due to their high usage,
the most expensive individual service items were sur-
geries, operations and organ replacements. From ap-
proximately 6000 different service items on the MBS,
study participants used only 751 different services
across the eight categories. For many of these services,
the number of study participants who had used the ser-
vice was not sufficient to support reliable estimates and
these services were removed from further analyses. Ser-
vices with usage patterns that were logically correlated
(e.g., skin biopsy followed by pathology service) were
identified and the relevant collinear items removed.
After removing the factors with low number of obser-
vations, three categories, 52 groups/subgroups and 66
items were included in the final MBS dataset.
PBS data
The PBS dataset contained 9846 records by 427 study
participants (58 %). Among more than 550 items that were
listed, rosuvastatin (a statin) and atenolol (a beta blocker)
were the most frequently occurring items.
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The most frequently occurring categories in the second
level were C09: Agents acting on the renin-angiotensin
system, C10: Lipid Modifying Agents, N02: Analgesics,
N06: Psychoanaleptics, and finally A02: Drugs for
Acid-related Disorders. After removing highly correlated
items, 20 PBS variables remained.
Transport accident compensation costs by category
From the total of 14.3 million dollars paid for injury-
related services among study participants in the 12 months
post-injury, more than 60 % was paid for hospital and
medical costs (Table 1).
For each of the cost categories, the data was further
divided into four time ranges: 1 month, 3 months,
6 months and 1 year. For some cost categories, the ma-
jority of expenses were clustered in the first month post-
accident (e.g. ambulance services) while other expenses
continued beyond the first 6 months (e.g. medical services).
The mean cost in the first month of non-hospitalised
clients was 4538 [95 % CI: 3424, 5652] compared to 32,044
[95 % CI: 27,526, 36,563] for hospitalised clients. The 3-
month cost increased to 5288 [95 % CI: 3951, 6625] for
non-hospitalised and 40,780 [95 % CI: 34,627, 46,933] for
hospitalised clients; and at 1 year the costs increased to
6970 [95 % CI: 5184, 8757] and 54,063 [95 % CI: 45,472,
62,654], respectively (all in Australian Dollars based on
2012 prices).
Cost of injury recovery: ambulance
Participants who used pre-injury diabetes medication
(ATC code A10: Drugs used in Diabetes) had $108.13
higher ambulance costs compared with those who did
not, for every prescription received in the year before
the accident [95 % CI: 75.10, 141.15]. Since the number
of prescriptions of diabetes medications for participants
who have received at least one prescription was distrib-
uted with the mean of 7.7 prescriptions per person and
standard deviation of 5.9, it is expected that each partici-
pant using diabetes drugs had, on average, approximately
$831 higher ambulance costs [95 % CI: 194, 1470].
Cost of injury recovery: hospital
Table 2 presents the pre-injury service items that were
statistically associated with post-injury hospital costs.
MBS Item 66512, Five or more tests from Quantitation
in serum, plasma, urine or other body fluid, is considered
as the highest ladder pathological item considered
mainly as a cost item for chronic conditions [1, 24, 33].
Three other pre-injury pathological services were associ-
ated with post-injury hospital costs indicating diabetes,
hepatitis and thyroids.
Cost of injury recovery: medical
Compensated medical services include consultations
(general practitioners, physicians, specialist, etc.), hos-
pital outpatient medical services, pathology and radi-
ology. Table 3 presents the main pre-injury factors
found to be associated with greater overall medical
recovery costs.
Participants who used anti-inflammatory and anti-
rheumatic drugs (mainly Meloxicam, Celecoxib, and
Diclofenac(L7), ophthalmological (L8) and diabetes
medications had, on average, higher medical recovery
costs. For example, in the first year after the injury,
each participant who used Anti-inflammatory and Anti-
rheumatic Products medication cost an extra $49.75
[95 % CI: 35.4, 64.12] compared to those who did not. In
the 12 months after the accident, patients who used
diabetes medications had close to 8 % higher medical
consultations cost than those not on diabetes medication.
Moreover, patients with electrocardiography in the
year before their injury were more likely to have medical
costs, in particular medical consultations. Surgery (iden-
tified through anaesthetic services and as well as specific
surgery procedure Medicare items) affects medical costs
as well. Short-term medical costs were also affected by
pathological tests, namely thyroid function tests and
prothrombin time test. While the coefficient of Thyroid
test was much larger than the Prothrombin test, it
should be noted that the average number of Thyroid
tests was two per person, compared to 17 per person for
Prothrombin time.
Total cost
None of the pre-injury MBS or PBS service items in-
cluded in the analysis was significantly associated with
the total injury compensation cost in either original or
log values.
Table 1 Cost categories and their share in total cost (in Australian Dollars)
Service group Count of items % Avg. cost of item Sum of cost %
Ambulance/Road accident rescue 848 1.34 % $1423.29 $ 1,206,954 8.45 %
Hospital 1287 2.03 % $4880.94 $ 6,281,771 43.96 %
Medical 21,818 34.47 % $120.40 $ 2,626,989 18.38 %
Total cost of health-related services $ 10,115,714 70.79 %
Total cost of non-health services $ 4,173,459 29.21 %
Total cost of services $ 14,289,173 100 %
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Discussion
This study has two main findings. The first is that pre-
injury health service use and corresponding health con-
ditions were not associated with the overall cost of re-
covery in our sample. Most estimates of the cost of
injury derived from administrative data sets are unable
to identify the pre-injury physical health of the injured
sample due to data limitation [25, 31]. The findings from
this study provide some confidence that the validity of
these cost-of-injury estimates is not significantly threat-
ened by this lack of pre-existing physical health data.
The second main finding of the study is heterogeneous
effect of pre-existing conditions on the post injury out-
comes. Not all costs of recovery were affected by the
pre-existing conditions; the effect was mainly restricted
to health service costs. Diabetes and cardiovascular con-
ditions had the highest level of impact on the subcat-
egories of post injury recovery costs such as medical
costs. Receiving surgery-related therapeutic services such
as general surgeries or anaesthesia in the year before the
accident were also associated with increases in some
cost categories such as post-injury hospital costs.
While the literature on the cost outcomes of patients
with traffic accidents Our findings are in line with earlier
studies indicating the increased risk of adverse outcomes
in patients with diabetes [2, 8, 18, 30], cardiovascular
conditions [20, 30, 34, 35] and surgeries [29, 36]. The sig-
nificant impact of having diabetes on the cost of recovery
can be explained. First, patients with diabetes are likely to
need monitoring of their diabetes during the acute phase
of the injury, and second, they are most likely to develop
complications such as delayed healing of wounds and in-
fections. The observed relationship between surgery in the
year before injury and increased cost of injury recovery
may be due to the lack of resilience that is manifest during
the post-surgery convalescence.
Our findings also highlight that the impact of pre-
existing chronic conditions on recovery outcomes is not
fully captured by easily observable demographic charac-
teristics such as age. Prevalence of pre-existing chronic
Table 2 The pre-injury service items that are statistically associated with the post-injury hospital cost (in Australian Dollars)
Variable Coefficientc
Outcome Variable: Post-injury Hospital Costa
Five or more tests from Quantitation in serum, plasma, urine or other body fluid (MBS Item 66500) $3799 [$2337, $5261]
Quantitation of glycosylated haemoglobin performed in the management of established diabetes (MBS Item 66551) $10,406.52 [$5467, $15,346]
Outcome Variable: Post-injury Hospital Cost, Loggedb
Anaesthetist, pre-anaesthesia consultation (MBS Sub Group T6-1) 0.24 [0.13, 0.36]
Two tests from tests for hepatitis antigen or antibodies to determine immune status or viral carriage following
exposure or vaccination to Hepatitis A, Hepatitis B, Hepatitis C or Hepatitis D (MBS Item 69475)
0.65 [0.37, 0.92]
Thyroid function tests (MBS Item 66719) 0.37 [0.06, 0.69]
aThe coefficient indicates the average change in the category cost for every extra item used from the services listed based on a linear model.
bThe coefficient indicates the average percentage change in the category cost for every extra item used from the services listed based on a nonlinear model.
c[95 % confidence interval]
Table 3 The pre-injury service and items which have significant impact on the medical costs of recovery after road traffic injury
(in Australian Dollars)
Variable Coefficientc
Outcome Variable: Post-injury Medical Costa
Cardiovascular diagnostics and investigation (MBS Sub Group D1-6) $76.44 [$54.27,$98.62]
Initiation of management of anaesthesia (MBS Sub Group T10-6) $257.65 [$174.16,$341.16]
Thyroid function tests (MBS Item 66719) $356.28 [$258.79, $453.78]
Prothrombin time test (MBS Item 65120) $26.77 [$15.02, $38.53]
Vascular Ultrasound (MBS Sub Group I1-3) $359.79 [$273.77, $445.82]
Radiographic examination of head (MBS Sub Group I3-3) $301.92 [$186.58, $417.28]
Drug for Anti-inflammatory and Anti-rheumatic Products (ATC Code M01) $49.75 [$35.4, $64.12]
Drugs for Sensory Organs (ATC Code S01) $31.48 [$23.04, $39.93]
Outcome Variable: Post-injury Medical Cost, Loggedb
Drugs used in diabetes (ATC Code A10) 0.08 [0.05, 0.11]
aThe coefficient indicates the average change in the category cost for every extra item used from the services listed based on a linear model.
bThe coefficient indicates the average percentage change in the category cost for every extra item used from the services listed based on a nonlinear model.
c[95 % confidence interval]
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conditions is likely to increase with age [2, 30, 35] and the
average age of drivers is increasing [6, 14]. Findings from
earlier studies suggest that older individuals’ sustained in-
juries appear more serious [15] and comorbidities and
complications among older patients are more likely to lead
to poorer hospital outcomes than younger counterparts
[6]. As we find that certain pre-injury health conditions
matter on recovery outcomes even after controlling for
age, the increased comorbidities and medical complica-
tions observed among older individuals may at least partly
be due to these specific conditions not necessarily due to
age per se.
The main strength of this study was the use of health
service records, before and after the injury to identify
the links between pre-injury comorbidities and post-
injury recovery. Considering the comprehensiveness of
the three datasets, MBS, PBS and TAC, the study was
able to provide more robust conclusions than studies
that use self-stated indicators, particularly self-reported
pre-injury health.
One of the weaknesses of this study is the low rate of
consent among potential study participants. There is a
participation bias with relative overrepresentation of
older persons in the study. Pharmaceutical and service
use is likely to be higher in the study sample than in the
underlying population. The prevalence of mental health
conditions, inferred from service and medication use, is
likely to be overestimated in this study; however, interval
validity of the correlations between mental health condi-
tions and the cost of recovery are unlikely to be affected.
Another weakness of the study is that Medicare items
were used as indicators of health conditions rather than
specific diagnosis variables. Medicare items include
many “investigative” services which may not necessarily
equate to morbidity. Furthermore, untreated disease
could not be identified using these data.
We used Bayesian Model Averaging to achieve robust
variables based on the Medicare and pharmaceutical
data, but this is not as effective as linking these data to
actual diagnostic data. Further research could include a
validation study of liked Medicare and pharmaceutical
records linked with hospital admission records including
ICD10 comorbidity codes. This may also provide an
estimate of the prevalence of untreated disease, which
may be picked up in the ICD10 codes but not in the
Medicare or pharmaceutical data.
And finally, many of the potentially informative pre-
injury health service items could not be included in the
analysis because they were not frequent enough in the
sample. The analysis can also be improved by using a larger
sample and by taking into account longer pre-injury and
post-injury time periods.
Future research should focus on analysing linked data
over longer pre- and post-injury durations as well as
including other datasets such as hospital admissions in
the linkage process.
Conclusions
This study shows that the services related to pre-existing
conditions, mainly chronic and surgery-related, are likely
to increase certain components of road trauma recovery
cost, but that overall pre-injury health service use has
little impact on the overall injury recovery costs. Also,
the impact of pre-existing chronic conditions on cost of
recovery cannot be fully attributed to age. Our findings
are expected to help the compensation agencies such as
TAC since better understanding of the drivers of traffic
accident compensation costs is a key step in: 1) deliver-
ing a fairer and further optimised system of providing
benefits to compensation and insurance clients through
better allocation of financial resources, 2) better internal
management of claims and efficient allocation of phys-
ical and human resources and therefore greater client
satisfaction, and 3) ensuring faster recovery, return to
work and more effective as well as efficient service
provision.
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